| Financial Year |
March 31 2023 |
| Monetary Funds |
756,873,903.27 |
| Held-for-trading Financial Assets |
240,158,832.21 |
| Notes Receivable |
-- |
| Accounts Receivable |
286,968,353.84 |
| Advances to Suppliers |
4,724,541.77 |
| Other Receivables |
47,581,090.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
17,201,908.33 |
| Dividend Receivable |
-- |
| Inventories |
1,591,280,322.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,667,545.07 |
| Total Current Assets |
3,574,230,773.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
297,024.58 |
| Investment Properties |
-- |
| Fixed Assetes |
496,364,871.39 |
| Under-construction Projects |
80,447,594.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
234,491,818.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
313,647.16 |
| Deferred Income Tax Assets |
51,737,404.24 |
| Other Non-Current Assets |
2,324,043.64 |
| Sub-Total of Non-Current Assets |
879,372,377.50 |
| Total Assets |
4,453,603,151.25 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
396,469,526.63 |
| Accounts Payable |
496,295,545.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
75,843,554.71 |
| Taxes Payable |
29,811,241.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
90,974,784.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,240,037.03 |
| Other Current Liabilities |
120,423,146.36 |
| Sub-Total of Current Liabilities |
2,175,819,545.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
47,430,190.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
156,696,395.65 |
| Total Liabilities |
2,332,515,941.30 |
| Paid-In Capital(Or Share Stock) |
522,000,000.00 |
| Capital Surplus |
290,414,240.69 |
| Surplus Reserve |
160,955,621.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,139,345,677.34 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,121,087,209.95 |
| Owner's Equity（Stockholder's Equity） |
2,121,087,209.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,453,603,151.25 |
